News

News
JNJ Press releases

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases

Read full story
JNJ Press releases

Johnson & Johnson Innovation to Join NXT Biomedical Therapeutic Device Incubator to Accelerate Medical Device Innovation

Read full story
JNJ Press releases

Global Corporate Venturing Rising Stars Awards 2018: #8 Stacy Feld

Read full story
JNJ Press releases

Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients’ Lives

Read full story
JNJ Press releases

Caelus Health joins the JLINX Community

Read full story
JNJ Press releases

Global Corporate Venturing Rising Stars Awards 2017: #19 Renee Ryan

Read full story
JNJ Press releases

Octimet Oncology joins the JLINX Community

Read full story
JNJ Press releases

Johnson & Johnson Innovation, New York State, and New York Genome Center Collaborate to Launch JLABS in New York City

Read full story
JNJ Press releases

Johnson & Johnson Innovation’s global pursuit of cutting-edge science yields 15 new collaborations, pushing the total above 300.

Read full story
JNJ Press releases

Vedanta Biosciences Announces License Agreement with Janssen and Johnson & Johnson Innovation for Microbiome

Read full story
JNJ Press releases

Janssen and Johnson & Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease

Read full story
JNJ Press releases

Johnson & Johnson Innovation Expands Global Incubator Presence to Israel and Announces Multiple, Diverse, Early-Stage Collaborations with Academia and Biotech

Read full story
JNJ Press releases

PhaseBio Pharmaceuticals, Inc. Raises $25 Million in Series B Funding, Initiates Collaboration with OSI Pharmaceuticals

Read full story